GLP-1 Agonists May Improve Longevity in Individuals with Severe Mental Illness
17/09/2026
Starting a GLP-1 receptor agonist was associated with significantly lower risks of death and cardiovascular events in adults with serious
Aprobación de un nuevo parche de terapia hormonal genérico Recentemente, la FDA aprobó el primer genérico del sistema transdérmico de…
Read more →Starting a GLP-1 receptor agonist was associated with significantly lower risks of death and cardiovascular events in adults with serious
Hormone replacement therapy (HRT) has been linked to a reduced risk of dementia according to a prospective study involving nearly
After ruling out a myocardial infarction (MI) in patients with suspected acute coronary syndrome (ACS), routine use of CT coronary
In a departure from other transcatheter aortic valve replacement (TAVR, or TAVI) trials, direct oral anticoagulant (DOAC, or NOAC) therapy
Expansión de cobertura para TAVR La cobertura de reemplazo aórtico transcatéter (TAVR) ha sido ampliada por el CMS. Se elimina